Genome-wide association study identifies CBFA2T3 affecting the rate of CSF Aβ(42) decline in non-demented elders

Brain amyloid deposition is an early pathological event in Alzheimer’s disease (AD), and abnormally low levels amyloid-β(42) peptide (Aβ(42)) in cerebrospinal fluid (CSF) can be detected in preclinical AD. To identify the genetic determinants that regulate the rate of CSF Aβ(42) decline among non-de...

Descripción completa

Detalles Bibliográficos
Autores principales: Dou, Kai-Xin, Zhang, Can, Tan, Chen-Chen, Xu, Wei, Li, Jie-Qiong, Cao, Xi-Peng, Tan, Lan, Yu, Jin-Tai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710044/
https://www.ncbi.nlm.nih.gov/pubmed/31370031
http://dx.doi.org/10.18632/aging.102125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710044/
https://www.ncbi.nlm.nih.gov/pubmed/31370031
http://dx.doi.org/10.18632/aging.102125

Ejemplares similares